Andreas Kalmes

995 total citations
22 papers, 852 citations indexed

About

Andreas Kalmes is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Andreas Kalmes has authored 22 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Andreas Kalmes's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cell Adhesion Molecules Research (3 papers). Andreas Kalmes is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Ubiquitin and proteasome pathways (3 papers) and Cell Adhesion Molecules Research (3 papers). Andreas Kalmes collaborates with scholars based in Germany, United States and Canada. Andreas Kalmes's co-authors include Alexander W. Clowes, Günter Daum, Gunter Merdes, Beate Neumann, Bernard M. Mechler, Judith A. Abraham, A W Clowes, Hans Heid, Ulf R. Rapp and Ludmilla Wixler and has published in prestigious journals such as Circulation, The Journal of Cell Biology and Journal of the American College of Cardiology.

In The Last Decade

Andreas Kalmes

21 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Kalmes Germany 13 616 282 104 93 75 22 852
Ha Kun Kim United States 7 808 1.3× 290 1.0× 140 1.3× 85 0.9× 91 1.2× 7 1.1k
Casey L. Moulson United States 12 770 1.3× 201 0.7× 81 0.8× 48 0.5× 67 0.9× 13 1.0k
Jianmin Lao United States 9 466 0.8× 216 0.8× 46 0.4× 44 0.5× 48 0.6× 9 960
Anthony Makkinje United States 13 794 1.3× 167 0.6× 186 1.8× 87 0.9× 51 0.7× 15 1.1k
Frances Kern Switzerland 15 371 0.6× 172 0.6× 52 0.5× 105 1.1× 98 1.3× 20 694
Marie-Annick Forget Canada 9 544 0.9× 298 1.1× 159 1.5× 140 1.5× 95 1.3× 11 815
Ian D. Tonks Australia 17 929 1.5× 227 0.8× 277 2.7× 169 1.8× 102 1.4× 26 1.3k
Rita Martinez United States 11 821 1.3× 118 0.4× 128 1.2× 65 0.7× 95 1.3× 13 1.2k
Laura Rosanò Italy 16 335 0.5× 160 0.6× 119 1.1× 80 0.9× 51 0.7× 35 592
W. Schmidt Germany 6 1.5k 2.4× 209 0.7× 90 0.9× 62 0.7× 124 1.7× 9 1.8k

Countries citing papers authored by Andreas Kalmes

Since Specialization
Citations

This map shows the geographic impact of Andreas Kalmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Kalmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Kalmes more than expected).

Fields of papers citing papers by Andreas Kalmes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Kalmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Kalmes. The network helps show where Andreas Kalmes may publish in the future.

Co-authorship network of co-authors of Andreas Kalmes

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Kalmes. A scholar is included among the top collaborators of Andreas Kalmes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Kalmes. Andreas Kalmes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghosh, Supurna, Wendy Smith, David Chiu, et al.. (2025). Randomized, Proof-of-Concept Trial (RESCUE) of RNS60 as an Adjunct Therapy in Acute Ischemic Stroke. Stroke. 56(9). 2386–2397.
2.
Li, Jie, Supurna Ghosh, Andreas Kalmes, et al.. (2024). Neuroprotective effect of the RNS60 in a mouse model of transient focal cerebral ischemia. PLoS ONE. 19(1). e0295504–e0295504. 1 indexed citations
3.
Nashed, Joseph Y., et al.. (2022). Abstract WP259: Acute Stroke Neuroprotection With Intravenous Rns60 In The Cynomolgus Macaque. Stroke. 53(Suppl_1). 1 indexed citations
4.
Zabielska-Kaczorowska, Magdalena A., et al.. (2022). Beneficial Effects of RNS60 in Cardiac Ischemic Injury. Current Issues in Molecular Biology. 44(10). 4877–4887. 1 indexed citations
5.
Vallarola, Antonio, Francesca Sironi, Massimo Tortarolo, et al.. (2018). RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue. Journal of Neuroinflammation. 15(1). 65–65. 36 indexed citations
6.
Kalmes, Andreas, Supurna Ghosh, & Richard L. Watson. (2013). A SALINE-BASED THERAPEUTIC CONTAINING CHARGE-STABILIZED NANOSTRUCTURES PROTECTS AGAINST CARDIAC ISCHEMIA/REPERFUSION INJURY. Journal of the American College of Cardiology. 61(10). E106–E106. 8 indexed citations
7.
Kalmes, Andreas, et al.. (2011). Abstract 17400: Charge-Stabilized Nanostructures Reduce Ischemia-Reperfusion Injury in A Pig Model in vivo. Circulation. 124(suppl_21). 5 indexed citations
8.
Chan, Anthony W.H., Andreas Kalmes, Suzanne Hawkins, Günter Daum, & Alexander W. Clowes. (2003). Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery. Journal of Vascular Surgery. 37(3). 644–649. 42 indexed citations
9.
Kalmes, Andreas, et al.. (2001). EGFR Transactivation in the Regulation of SMC Function. Annals of the New York Academy of Sciences. 947(1). 42–55. 81 indexed citations
11.
Kalmes, Andreas, et al.. (1999). Raf‐1 is activated by the p38 mitogen‐activated protein kinase inhibitor, SB203580. FEBS Letters. 444(1). 71–74. 78 indexed citations
12.
Daum, Günter, et al.. (1998). Pervanadate inhibits mitogen‐activated protein kinase kinase‐1 in a p38MAPK‐dependent manner. FEBS Letters. 427(2). 271–274. 21 indexed citations
13.
Hagemann, Carsten, Andreas Kalmes, Viktor Wixler, et al.. (1997). The regulatory subunit of protein kinase CK2 is a specific A‐Raf activator. FEBS Letters. 403(2). 200–202. 84 indexed citations
14.
Kalmes, Andreas, Gunter Merdes, Beate Neumann, Dennis Strand, & Bernard M. Mechler. (1996). A serine-kinase associated with the p127-l(2)gl tumour suppressor of Drosophila may regulate the binding of p127 to nonmuscle myosin II heavy chain and the attachment of p127 to the plasma membrane. Journal of Cell Science. 109(6). 1359–1368. 54 indexed citations
15.
Strand, David, Heide Schenkel, Andreas Kalmes, et al.. (1995). A human homologue of the Drosophila tumour suppressor gene l(2)gl maps to 17p11.2-12 and codes for a cytoskeletal protein that associates with nonmuscle myosin II heavy chain.. PubMed. 11(2). 291–301. 76 indexed citations
16.
Strand, Dennis, Heide Schenkel, Andreas Kalmes, et al.. (1995). A human homologue to theDrosophila tumour-suppressor gene,l(2)gl, is associated with nonmuscle myosin II heavy chain. Journal of Cancer Research and Clinical Oncology. 121(S1). A67–A67. 1 indexed citations
17.
Török, I., et al.. (1993). The l(2)gl homologue of Drosophila pseudoobscura suppresses tumorigenicity in transgenic Drosophila melanogaster.. PubMed. 8(6). 1537–49. 19 indexed citations
18.
Strand, Dennis, et al.. (1991). Transcriptional and translational regulation of the expression of the l(2)gl tumor suppressor gene of Drosophila melanogaster. Advances in Enzyme Regulation. 31. 339–350. 5 indexed citations
19.
Mechler, Bernard M., et al.. (1991). Drosophila as a model system for molecular analysis of tumorigenesis.. Environmental Health Perspectives. 93. 63–71. 13 indexed citations
20.
Mechler, Bernard M., et al.. (1991). Drosophila As a Model System for Molecular Analysis of Tumorigenesis. Environmental Health Perspectives. 93. 63–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026